Cargando…
Tumor Cell-Intrinsic Immunometabolism and Precision Nutrition in Cancer Immunotherapy
One of the greatest challenges in the cancer immunotherapy field is the need to biologically rationalize and broaden the clinical utility of immune checkpoint inhibitors (ICIs). The balance between metabolism and immune response has critical implications for overcoming the major weaknesses of ICIs,...
Autores principales: | Cuyàs, Elisabet, Verdura, Sara, Martin-Castillo, Begoña, Alarcón, Tomás, Lupu, Ruth, Bosch-Barrera, Joaquim, Menendez, Javier A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7409312/ https://www.ncbi.nlm.nih.gov/pubmed/32630618 http://dx.doi.org/10.3390/cancers12071757 |
Ejemplares similares
-
Metabolomic mapping of cancer stem cells for reducing and exploiting tumor heterogeneity
por: Cuyàs, Elisabet, et al.
Publicado: (2017) -
Clinical Management of COVID-19 in Cancer Patients with the STAT3 Inhibitor Silibinin
por: Bosch-Barrera, Joaquim, et al.
Publicado: (2021) -
Circulating levels of MOTS-c in patients with breast cancer treated with metformin
por: Cuyàs, Elisabet, et al.
Publicado: (2022) -
In silico clinical trials for anti-aging therapies
por: Menendez, Javier A., et al.
Publicado: (2019) -
Metformin as an archetype immuno-metabolic adjuvant for cancer immunotherapy
por: Verdura, Sara, et al.
Publicado: (2019)